HL7 Terminology (THO)
6.1.0 - Continuous Process Integration (ci build) International flag

HL7 Terminology (THO), published by HL7 International - Vocabulary Work Group. This guide is not an authorized publication; it is the continuous build for version 6.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/UTG/ and changes regularly. See the Directory of published versions

: Health Canada Drug Product Database - Schedule - JSON Representation

Active as of 2024-11-04

Raw json | Download

{
  "resourceType" : "CodeSystem",
  "id" : "ca-hc-dpd-schedule",
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: CodeSystem ca-hc-dpd-schedule</b></p><a name=\"ca-hc-dpd-schedule\"> </a><a name=\"hcca-hc-dpd-schedule\"> </a><a name=\"ca-hc-dpd-schedule-en-US\"> </a><p>This case-insensitive code system <code>http://terminology.hl7.org/CodeSystem/ca-hc-dpd-schedule</code> defines codes, but no codes are represented here</p></div>"
  },
  "url" : "http://terminology.hl7.org/CodeSystem/ca-hc-dpd-schedule",
  "identifier" : [
    {
      "system" : "urn:ietf:rfc:3986",
      "value" : "urn:oid:2.16.840.1.113883.5.1151"
    }
  ],
  "version" : "1.0.0",
  "name" : "Health_Canada_DPD_Schedule",
  "title" : "Health Canada Drug Product Database - Schedule",
  "status" : "active",
  "experimental" : false,
  "date" : "2024-11-04T00:00:00-00:00",
  "publisher" : "Health Canada, Health Products and Food Branch",
  "contact" : [
    {
      "name" : "Health Canada; Health Products and Food Branch; Address Locator 1801B, Ottawa, Ontario, K1A 0K9",
      "telecom" : [
        {
          "system" : "url",
          "value" : "https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html"
        },
        {
          "system" : "email",
          "value" : "pharma_drug_enquiries-renseignements_medicaments_pharma@hc-sc.gc.ca"
        },
        {
          "system" : "phone",
          "value" : "1-613-957-2991"
        }
      ]
    }
  ],
  "description" : "The Code System describes the characteristics of drugs for use in Canada.\r\n\r\nDrugs in Canada are assigned one or more of the following schedules, according to the Food and Drug Regulations, and the Controlled Drugs and Substances Act.\r\n\r\n- Prescription (prescription drugs included in the Prescription Drug List)\r\n\r\n- Prescription Recommended (drugs that are recommended to be listed on the Prescription Drug List)\r\n\r\n- Schedule G (control drugs)\r\n\r\n- Schedule G (Controlled Drugs and Substances Act [CDSA] III)\r\n\r\n- Schedule G (CDSA IV)\r\n\r\n- Schedule C (drugs listed in Schedule C of the Food and Drugs Act, for example, radiopharmaceutical drugs)\r\n\r\n- Schedule D (drugs listed in Schedule D of the Food and Drugs Act, ie. biological products)\r\n\r\n- Narcotic (Narcotic Control Act)\r\n\r\n- Narcotic (CDSA I)\r\n\r\n- Narcotic (CDSA II)\r\n\r\n- Targeted (CDSA IV)\r\n\r\n- CDSA Recommended- Undergoing Regulatory Amendment to add this new substance to Controlled Drugs Substances Act\r\n\r\n- OTC (over the counter drugs that do not appear on a schedule or are not recommended to appear on any schedule)\r\n\r\n- Ethical: a drug that, in accordance with Federal Legislation, does not require a prescription, but that is generally prescribed by a medical practitioner. Ethical products are unscheduled non-prescription professional use products (e.g. MRI contrast agents, hemodialysis solutions) and a few emergency use products (e.g. nitroglycerine)",
  "caseSensitive" : false,
  "content" : "not-present"
}